Clinical Trials Directory

Trials / Sponsors / Nanjing Leads Biolabs Co.,Ltd

Nanjing Leads Biolabs Co.,Ltd

Industry · 18 registered clinical trials — 12 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]
Advanced Solid Tumour
Phase 22026-04-01
RecruitingA Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ES
Advanced Solid Tumour
Phase 22026-02-26
RecruitingA Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
Triple Negative Breast Cancer
Phase 1 / Phase 22026-01-27
RecruitingA Phase I Study to Assess LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 12025-12-16
RecruitingA Phase Ib/Ⅱ Clinical Trial of LBL-024 Combined With Paclitaxel in Patients With Platinum-resistant Ovarian Ca
Ovarian Cancer
Phase 1 / Phase 22025-12-02
RecruitingA Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]
Advanced Solid Tumour
Phase 22025-10-20
RecruitingA Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanom
Advanced Melanoma
Phase 1 / Phase 22025-09-05
RecruitingA Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]
Advanced Solid Tumour
Phase 22025-06-11
RecruitingA Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carc
Advanced Neuroendocrine Carcinoma
Phase 1 / Phase 22023-12-08
RecruitingA Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma
Relapsed/Refractory Multiple Myeloma
Phase 1 / Phase 22023-10-20
RecruitingA Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors
Advanced Malignant Tumors
Phase 1 / Phase 22023-04-14
CompletedA Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors
Malignant Tumors
Phase 1 / Phase 22022-09-01
CompletedEvaluation of LBL-019 Monotherapy or Combined With Anti-PD-1 Antibody in the Treatment of Advanced Malignant T
Advanced Malignant Tumors
Phase 1 / Phase 22022-04-19
RecruitingA Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors
Advanced Solid Tumor
Phase 1 / Phase 22022-01-06
CompletedEvaluation of LBL-003 Phase I Study in Patients With Advanced Malignancies
Advanced Malignant Tumor
Phase 12021-12-02
CompletedA Phase Ib/II Clinical Study of LBL-007 in Combination With Toripalimab in Treatment of Advanced Malignant Tum
Advanced Malignant Tumors
Phase 1 / Phase 22021-11-30
CompletedPhase I/II Clinical Trial of LBL-015 for Injection
Advanced Malignant Tumor
Phase 1 / Phase 22021-11-08
CompletedA Study to Assess LBL-007 in Combination With Toripalimab and Axitinib Tablets Subjects With Advanced Melanoma
Advanced Melanoma
Phase 12020-05-12